chr20-2483197-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_024325.6(ZNF343):āc.1764T>Gā(p.His588Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000080 ( 0 hom., cov: 33)
Exomes š: 0.000032 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ZNF343
NM_024325.6 missense
NM_024325.6 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: -5.48
Genes affected
ZNF343 (HGNC:16017): (zinc finger protein 343) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.014509827).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF343 | NM_024325.6 | c.1764T>G | p.His588Gln | missense_variant | 6/6 | ENST00000278772.9 | NP_077301.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF343 | ENST00000278772.9 | c.1764T>G | p.His588Gln | missense_variant | 6/6 | 2 | NM_024325.6 | ENSP00000278772 | P1 | |
ZNF343 | ENST00000612935.4 | c.1887T>G | p.His629Gln | missense_variant | 8/8 | 5 | ENSP00000482819 | |||
ZNF343 | ENST00000617391.4 | c.1494T>G | p.His498Gln | missense_variant | 4/4 | 4 | ENSP00000483851 | |||
ZNF343 | ENST00000465019.1 | n.1792T>G | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 12AN: 149260Hom.: 0 Cov.: 33 FAILED QC
GnomAD3 genomes
AF:
AC:
12
AN:
149260
Hom.:
Cov.:
33
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000132 AC: 33AN: 249274Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134662
GnomAD3 exomes
AF:
AC:
33
AN:
249274
Hom.:
AF XY:
AC XY:
16
AN XY:
134662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000315 AC: 46AN: 1459338Hom.: 0 Cov.: 31 AF XY: 0.0000386 AC XY: 28AN XY: 725884
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
46
AN:
1459338
Hom.:
Cov.:
31
AF XY:
AC XY:
28
AN XY:
725884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000803 AC: 12AN: 149384Hom.: 0 Cov.: 33 AF XY: 0.0000821 AC XY: 6AN XY: 73082
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
12
AN:
149384
Hom.:
Cov.:
33
AF XY:
AC XY:
6
AN XY:
73082
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.1764T>G (p.H588Q) alteration is located in exon 6 (coding exon 4) of the ZNF343 gene. This alteration results from a T to G substitution at nucleotide position 1764, causing the histidine (H) at amino acid position 588 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N;.;.
REVEL
Benign
Sift
Benign
T;.;.
Sift4G
Benign
T;T;T
Polyphen
B;.;.
Vest4
MutPred
Gain of MoRF binding (P = 0.11);.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at